Get startedLog in
    Picture of PCI Biotech Holding ASA logo

    PCIBo — PCI Biotech Holding ASA News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: PCI Biotech: initial results from fimaVACC Phase I

    Picture of PCI Biotech Holding ASA logoPCI Biotech Holding ASA
    12/09/2017 07:04
    Sept 12 (Reuters) - PCI BIOTECH HOLDING ASA  PCIB.OL  
    * FIRST IMMUNE RESPONSE RESULTS FROM FIMAVACC PHASE I STUDY 
INDICATE ENHANCED OVERALL T-CELL RESPONSES AT TOLERABLE DOSE 
LEVELS. 
 
Source text for Eikon:  ID:nNDL2yBpkD  
Further company coverage:  PCIB.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on PCI Biotech Holding ASA

    See all news